# A Study of PD1 Combined With DC-NK Cell in the Treatment of Solid Tumors

> **NCT03815084** · EARLY_PHASE1 · UNKNOWN · sponsor: **Allife Medical Science and Technology Co., Ltd.** · enrollment: 100 (estimated)

## Conditions studied

- Solid Tumor

## Interventions

- **DRUG:** pd-1 and DC-NK cells

## Key facts

- **NCT ID:** NCT03815084
- **Lead sponsor:** Allife Medical Science and Technology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-02-01
- **Primary completion:** 2020-02-01
- **Final completion:** 2021-02-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2019-01-30

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03815084

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03815084, "A Study of PD1 Combined With DC-NK Cell in the Treatment of Solid Tumors". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03815084. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*